We need help to find a way to prevent COVID-19

COVID-19 studies are enrolling now.

Those who qualify:*

  • may receive the investigational vaccine or placebo at no cost
  • may receive compensation for time and travel
  • may receive free testing for COVID-19

Organ transplant patients are experiencing issues with the COVID-19 vaccine. Here’s why – WFTV

ORANGE COUNTY, Fla. — Charlie Fink is alive today from the gift of organ transplant.

But he takes medicine to quiet his immune system so his body won’t reject someone else’s kidney. And those immunosuppressants impacted the level of protection he’s received from the COVID-19 vaccine.

And he’s not alone.

READ: See where you can find the COVID-19 vaccine in your county

A John Hopkins Study shows that only 17% of organ transplant patients showed antibodies after the first shot.

Dr. Aftab Khan said he’s worried people on immunosuppressants will have a false sense of security from the shot, not realizing the drugs they’re on may interfere with their immune system’s ability to create antibodies.

In the John Hopkins study, the number of transplant patients with antibodies improved to 54% after the second shot. But that still means nearly half are left unprotected.

READ: Orange County officials working to fight misinformation to increase COVID-19 vaccinations rates

John Hopkins suggest a third booster shot may be the answer for those patients.


Source link

Share this post

Share on facebook
Share on twitter
Share on linkedin
Share on pinterest
Share on print
Share on email

Enhancing Exposure to European Equities

By Alejandro Saltiel, CFA Associate Director, Research European equity markets have shown strength this year, rebounding from last year’s pandemic-related slowdown…

We need help to find a way to prevent COVID-19

COVID-19 studies are enrolling now.

Those who qualify:*

  • may receive the investigational vaccine or placebo at no cost
  • may receive compensation for time and travel
  • may receive free testing for COVID-19